Hosted by Exyte. The discussion points for this session include but not limited to-
• Personalized medicine require rethinking logistics and manufacturing facilities
• Miniaturization of the manufacturing systems with full automation, fully integrated manufacturing platforms, what are the benefits and compromises?
• Manufacturing hubs and small scale onsite therapy manufacturing, what direction will prevail?
• Cut Cost of Goods and Time to Market in a competitive market, how can Pharma 4.0 help?